Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Robberecht

Showing results (181-190 of 290) with videos related to

Pageof 29
Sort By:
Peptides|January 1, 1991
Comparative in vitro effects of guinea pig VIP and common VIP on liver and lung membranes from guinea pig and rat and on human lymphoblastic SUP-T1 membranesA Cauvin, L Buscail, P Gourlet, et al.
Biochemical and Biophysical Research Communications|January 26, 1996
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretinJ P Vilardaga, E di Paolo, P de Neef, et al.
Journal of Molecular Endocrinology|June 1, 1996
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal glandP Vertongen, M Delhase, F Rajas, et al.
Endocrinology|October 1, 1994
Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23P Vertongen, E Ciccarelli, M C Woussen-Colle, et al.
Peptides|January 1, 1986
Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from ratP Robberecht, M Waelbroeck, J C Camus, et al.
Endocrinology|June 1, 1985
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonistM Waelbroeck, P Robberecht, D H Coy, et al.
Immunobiology|October 1, 1989
Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic typesP Robberecht, J Abello, C Damien, et al.
Biochimica Et Biophysica Acta|June 27, 1997
The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteinsJ Van Rampelbergh, P Poloczek, I Françoys, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discriminationJ P Vilardaga, P De Neef, E Di Paolo, et al.
Life Sciences|December 8, 1980
Postnatal development of the cholecystokinin-gastrin family of peptides in the brain and gut of ratM Noyer, N D Bui, M Deschodt-Lanckman, et al.
Pageof 29

Showing results (181-190 of 290) with videos related to

Sort By:
Pageof 29
Peptides|January 1, 1991
Comparative in vitro effects of guinea pig VIP and common VIP on liver and lung membranes from guinea pig and rat and on human lymphoblastic SUP-T1 membranesA Cauvin, L Buscail, P Gourlet, et al.
Biochemical and Biophysical Research Communications|January 26, 1996
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretinJ P Vilardaga, E di Paolo, P de Neef, et al.
Journal of Molecular Endocrinology|June 1, 1996
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal glandP Vertongen, M Delhase, F Rajas, et al.
Endocrinology|October 1, 1994
Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23P Vertongen, E Ciccarelli, M C Woussen-Colle, et al.
Peptides|January 1, 1986
Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from ratP Robberecht, M Waelbroeck, J C Camus, et al.
Endocrinology|June 1, 1985
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonistM Waelbroeck, P Robberecht, D H Coy, et al.
Immunobiology|October 1, 1989
Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic typesP Robberecht, J Abello, C Damien, et al.
Biochimica Et Biophysica Acta|June 27, 1997
The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteinsJ Van Rampelbergh, P Poloczek, I Françoys, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discriminationJ P Vilardaga, P De Neef, E Di Paolo, et al.
Life Sciences|December 8, 1980
Postnatal development of the cholecystokinin-gastrin family of peptides in the brain and gut of ratM Noyer, N D Bui, M Deschodt-Lanckman, et al.
Pageof 29